Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

@article{Punja2016AmphetaminesFA,
  title={Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.},
  author={Salima Punja and Larissa Shamseer and Lisa Hartling and Liana Urichuk and B. Vandermeer and Jane Nikles and Sunita Vohra},
  journal={The Cochrane database of systematic reviews},
  year={2016},
  volume={2},
  pages={
          CD009996
        }
}
BACKGROUND Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric conditions affecting children and adolescents. Amphetamines are among the most commonly prescribed medications to manage ADHD. There are three main classes of amphetamines: dexamphetamine, lisdexamphetamine and mixed amphetamine salts, which can be further broken down into short- and long-acting formulations. A systematic review assessing their efficacy and safety in this population has never been… 
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
TLDR
Low- to very low-quality evidence is found suggesting that amphetamines reduced the severity of ADHD symptoms as rated by clinicians, and no studies that had low risk of bias in all domains of the Cochrane 'Risk of bias' tool are found.
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
TLDR
Very low-certainty evidence is found that, compared with placebo, IR methylphenidate may reduce the clinical impression of the severity of ADHD symptoms and the effect of IR methyl Phenidate on ADHD symptoms was moderate, but the certainty of the evidence is very low.
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
TLDR
A large number of randomised, double-blind, parallel-group trials comparing extended-release methylphenidate formulations at any dose versus placebo and other ADHD medications in adults diagnosed with ADHD found very low-certainty evidence thatmethylphenidate had no effect on 'days missed at work' at 13-week follow-up and selective outcome reporting.
A review of Cochrane reviews on pharmacological treatment for attention deficit hyperactivity disorder
TLDR
Treatment with tricyclic antidepressants, amphetamine, and methylphenidate in children and adolescents with ADHD seems to present positive effects and higher rates of minor adverse events when compared to placebo.
The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials
TLDR
Clinical differences may exist between the pharmacological and non-pharmacological treatment used for the management of ADHD and there is lack of evidence for cognitive training, neurofeedback, antidepressants, antipsychotics, dietary therapy, fatty acids, and other complementary and alternative medicine.
Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review
TLDR
Evidence for the efficacy of treatment of patients with comorbid stimulant use disorder and attention deficit hyperactivity disorder is limited and promising outcomes need replication in further studies utilising higher treatment dosage.
Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder
TLDR
The stimulants LDX and MPH are still highly recommended because they are highly effective and are tolerated well by patients and among the non-stimulants, CLON can be taken into consideration for its appreciable effectiveness and tolerability.
Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
  • R. Rodrigues, M. Lai, S. Ameis
  • Psychology, Medicine
    Journal of child psychology and psychiatry, and allied disciplines
  • 2020
TLDR
Direct pooled evidence supports the efficacy and tolerability of methylphenidate or atomoxetine for treatment of ADHD symptoms in children and youth with ASD.
Triple-Bead Mixed Amphetamine Salt for ADHD
TLDR
In June 2017, long-acting, triple-bead mixed amphetamine salt (MAS) was FDA-approved under the brand name Mydayis for the once-daily treatment of ADHD in adolescents and adults, and patients may experience an onset of action within 2 to 4 hours following administration.
...
...

References

SHOWING 1-10 OF 101 REFERENCES
Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.
TLDR
The three amphetamine derivatives investigated (dextroamphetamine, lisdexamphetamine and mixed amphetamine salts) were all efficacious for reducing ADHD symptoms, but MAS also increased retention in treatment, and amphetamines improved short-term ADHD symptom severity.
Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.
TLDR
Many symptoms commonly attributed to stimulant medication are actually preexisting characteristics of children with ADHD and improve with stimulant treatment.
Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.
TLDR
The results of this long-term, placebo-controlled study of the central stimulant amphetamine in the treatment of ADHD indicate that there are remaining positive effects of the drug 15 months after starting treatment.
Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder.
TLDR
Single-dose treatments of Adderall appear to be as effective as 2 daily doses of MPH and therefore increase the possibility of managing treatment without involving the school in medication administration.
Challenges to determining adolescent medication response in an outpatient clinical setting: Comparing Adderal and methylphenidate for ADHD
TLDR
It is concluded that both Adderall and MPH appear to be clinically effective in the treatment of ADHD in teenagers, based on clinician's global impressions.
Stimulant medications for the treatment of ADHD: Efficacy and limitations
TLDR
This article provides an update of the “review of reviews” by identifying new investigations relevant to critical areas that might change the consensus views, and summarizes the recent presentations of the initial results of the MTA Study, which addresses many of the critical issues.
...
...